Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
NCT ID:
NCT07078266
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Presence of myocardial ischemia-related symptoms (e.g., angina pectoris) with suspected CHD or CMVD, scheduled for ECT examination
* Signed informed consent form
Exclusion Criteria:
* Hemodynamic instability (systolic blood pressure \<90 mmHg or requiring vasoactive drugs);
* Cardiac arrhythmias, including ventricular tachycardia, ventricular fibrillation, severe sinus bradycardia and sinus pauses, and second - degree or higher - degree atrioventricular block and other severe arrhythmias;
* Aortic dissection aneurysm, severe aortic valve stenosis or insufficiency;
* Elderly or frail patients with neuromuscular or osteoarticular diseases who cannot complete exercise stress ECT; Allergy to drugs used in pharmacologic stress ECT;
* Patients with severe renal insufficiency with an estimated glomerular 6.filtration rate (eGFR) \< 30 ml/min or those undergoing dialysis;
* Patients with malignant tumors and a life - expectancy of less than1 year;
* Pregnant or lactating women;
* Patients unable to undergo MCG examination due to inability to enter the chamber, metallic implant interference, or other conditions deemed unsuitable by researchers.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07078266
Study Brief:
Protocol Section:
NCT07078266